The federal health agency of Canada, Health Canada, released approximately 770 mislabelled bottles of cannabis oil capsules in New Brunswick. Following this, the agency has issued a recall of these capsules.
The capsules, labeled as Namaste CBD Light gelcaps, were THC gelcaps. Tetrahydrocannabinol (THC) is the psychoactive compound in marijuana. When used or taken, this can make the user undergo a state of intoxication and may alter their current state of mind.
Zenabis Ltd. is the main producer of the said products. The retailer for the said products is Cannabis NB.
The gelcaps were reportedly labeled as 6.13 milligrams of cannabidiol, alongside 0.19 milligrams of tetrahydrocannabinol. The products were recalled upon discovering that the capsules released to the public did not have CBD. Instead, it contained 2.247 milligrams of THC.
In a notice released by Health Canada, the agency revealed that 786 CBD products were sold last October 7, 2019. Each bottle contained 15 capsules.
Zenabis spokesperson Jordan Owens revealed in a statement that “Cannabis NB has confirmed to us that 603 units are still in stock (i.e. unsold) to be returned to Zenabis.”
Despite not receiving any complaints, the department decided to issue a recall on the products on just this Tuesday, December 17, 2019. Meanwhile, Zenabis Ltd. only received one complaint pertaining to the recalled batch.
In a statement, Health Canada said, “These units contain the incorrect cannabis product. The label indicates that the product is ‘CBD Light gelcaps. However, the units contain THC gelcaps.”
This event is the second unfortunate incident to hit Zenabis Ltd.in a short period. This 2019, a prior mishap also occurred due to mislabelling their products.
Per TheGrowthOp, Zenabis Ltd. sold a batch of Wappa dried flowers and labelled the product with 6.57 percent THC and 12.1 percent CBD. However, TheGrowthOp says that the actual content comes up to a whopping 17.3 percent THC and 0.07 CBD.
Voluntary Recall on Cannabis Oil Capsules
Following this incident, Zenabis Ltd. reportedly issued a voluntary product recall after it sold the said batch via the Société québecoise du cannabis platform.
In the event consumers have purchased goods that are part of the recall list, the Canadian agency urges customers to return it immediately. Moreover, concerned individuals may also reach out to Cannabis NB at 1-833-821-2195.
Though Cannabis NB said it had already “posted notices for customers to make them aware of the recall,” CBC reports that the business has yet to post the incident or the recall on their page or in their respective social media platforms.
The capsules, labeled as Namaste CBD Light gelcaps, were THC gelcaps. Tetrahydrocannabinol (THC) is the psychoactive compound in marijuana. When used or taken, this can make the user undergo a state of intoxication and may alter their current state of mind.
Zenabis Ltd. is the main producer of the said products. The retailer for the said products is Cannabis NB.
The gelcaps were reportedly labeled as 6.13 milligrams of cannabidiol, alongside 0.19 milligrams of tetrahydrocannabinol. The products were recalled upon discovering that the capsules released to the public did not have CBD. Instead, it contained 2.247 milligrams of THC.
In a notice released by Health Canada, the agency revealed that 786 CBD products were sold last October 7, 2019. Each bottle contained 15 capsules.
Zenabis spokesperson Jordan Owens revealed in a statement that “Cannabis NB has confirmed to us that 603 units are still in stock (i.e. unsold) to be returned to Zenabis.”
Despite not receiving any complaints, the department decided to issue a recall on the products on just this Tuesday, December 17, 2019. Meanwhile, Zenabis Ltd. only received one complaint pertaining to the recalled batch.
In a statement, Health Canada said, “These units contain the incorrect cannabis product. The label indicates that the product is ‘CBD Light gelcaps. However, the units contain THC gelcaps.”
This event is the second unfortunate incident to hit Zenabis Ltd.in a short period. This 2019, a prior mishap also occurred due to mislabelling their products.
Per TheGrowthOp, Zenabis Ltd. sold a batch of Wappa dried flowers and labelled the product with 6.57 percent THC and 12.1 percent CBD. However, TheGrowthOp says that the actual content comes up to a whopping 17.3 percent THC and 0.07 CBD.
Voluntary Recall on Cannabis Oil Capsules
Following this incident, Zenabis Ltd. reportedly issued a voluntary product recall after it sold the said batch via the Société québecoise du cannabis platform.
In the event consumers have purchased goods that are part of the recall list, the Canadian agency urges customers to return it immediately. Moreover, concerned individuals may also reach out to Cannabis NB at 1-833-821-2195.
Though Cannabis NB said it had already “posted notices for customers to make them aware of the recall,” CBC reports that the business has yet to post the incident or the recall on their page or in their respective social media platforms.
